Pedersen, Christine Aaserød
Cao, Maria Dung
Fleischer, Thomas
Rye, Morten B.
Knappskog, Stian
Eikesdal, Hans Petter
Lønning, Per Eystein
Tost, Jörg
Kristensen, Vessela N.
Tessem, May-Britt
Giskeødegård, Guro F.
Bathen, Tone F.
Funding for this research was provided by:
Stiftelsen Kristian Gerhard Jebsen
Horizon 2020 (758306)
Kreftforeningen (6834362)
Liaison committee between the Central Norway Health Authority and NTNU
Kreftforeningen, Norway (202021)
The joint research committee between St. Olavs Hospital and the Faculty of Medicine and Health Sciences, NTNU (28328)
NTNU Norwegian University of Science and Technology
Article History
Received: 6 December 2021
Accepted: 3 June 2022
First Online: 24 June 2022
Change Date: 1 September 2022
Change Type: Update
Change Details: In the online version of this article, the funding note should be updated. The article has been updated.
Declarations
:
: This study was approved by the regional ethics committee #273/96-82.96 and 50724/2019., Norwegian Health Region III, and written informed consent was obtained from all patients included in this study.
: Not applicable.
: The authors declare that they have no competing interests.